Overview
FDA & Trial Timeline
1 eventECOG-ACRIN Cancer Research Group — PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Thymic neuroendocrine carcinoma.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Thymic neuroendocrine carcinoma at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersKingman Regional Medical Center
📍 Kingman, Arizona
PCR Oncology
📍 Arroyo Grande, California
CHI Saint Vincent Cancer Center Hot Springs
📍 Hot Springs, Arkansas
Cancer Center at Saint Joseph's
📍 Phoenix, Arizona
Mercy Hospital Fort Smith
📍 Fort Smith, Arkansas
Alta Bates Summit Medical Center-Herrick Campus
📍 Berkeley, California
USC / Norris Comprehensive Cancer Center
📍 Los Angeles, California
👤 Ann (Annie) W Silk
Kaiser Permanente-Deer Valley Medical Center
📍 Antioch, California
Travel Grants
No travel grants are currently matched to Thymic neuroendocrine carcinoma.
Community
No community posts yet. Be the first to share your experience with Thymic neuroendocrine carcinoma.
Start the conversation →Latest news about Thymic neuroendocrine carcinoma
Disease timeline:
New trial: Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differ
Phase PHASE2 trial recruiting. Capecitabine
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Thymic neuroendocrine carcinoma
Which specialists treat Thymic neuroendocrine carcinoma?
19 specialists and care centers treating Thymic neuroendocrine carcinoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.